|
1
|
Oguma K, Oshima H and Oshima M:
Inflammation, tumor necrosis factor and Wnt promotion in gastric
cancer development. Future Oncol. 6:515–526. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ernst P: Review article: the role of
inflammation in the pathogenesis of gastric cancer. Aliment
Pharmacol Ther. 13(Suppl 1): S13–S18. 1999. View Article : Google Scholar
|
|
3
|
Fox JG and Wang TC: Inflammation, atrophy,
and gastric cancer. J Clin Invest. 117:60–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Multhoff G, Molls M and Radons J: Chronic
inflammation in cancer development. Front Immunol. 2:982012.
View Article : Google Scholar :
|
|
5
|
Mosaffa F, Kalalinia F, Lage H, Afshari JT
and Behravan J: Pro-inflammatory cytokines interleukin-1 beta,
interleukin 6, and tumor necrosis factor-alpha alter the expression
and function of ABCG2 in cervix and gastric cancer cells. Mol Cell
Biochem. 363:385–393. 2012. View Article : Google Scholar
|
|
6
|
Chen CC, Chu CB, Liu KJ, Huang CY, Chang
JY, Pan WY, Chen HH, Cheng YH, Lee KD, Chen MF, et al: Gene
expression profiling for analysis acquired oxaliplatin resistant
factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6
signaling and Nrf2/AKR1C axis identification. Biochem Pharmacol.
86:872–887. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schmitz J, Owyang A, Oldham E, Song Y,
Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et
al: IL-33, an interleukin-1-like cytokine that signals via the IL-1
receptor-related protein ST2 and induces T helper type 2-associated
cytokines. Immunity. 23:479–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shen Z, Seppänen H, Vainionpää S, Ye Y,
Wang S, Mustonen H and Puolakkainen P: IL10, IL11, IL18 are
differently expressed in CD14+ TAMs and play different
role in regulating the invasion of gastric cancer cells under
hypoxia. Cytokine. 59:352–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mohran ZY, Ali-Eldin FA and Abdel Aal HA:
Serum interleukin-18: does it have a role in the diagnosis of
hepatitis C virus related hepatocellular carcinoma? Arab J
Gastroenterol. 12:29–33. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsuboi K, Miyazaki T, Nakajima M, Fukai Y,
Masuda N, Manda R, Fukuchi M, Kato H and Kuwano H: Serum
interleukin-12 and interleukin-18 levels as a tumor marker in
patients with esophageal carcinoma. Cancer Lett. 205:207–214. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thong-Ngam D, Tangkijvanich P, Lerknimitr
R, Mahachai V, Theamboonlers A and Poovorawan Y: Diagnostic role of
serum interleukin-18 in gastric cancer patients. World J
Gastroenterol. 12:4473–4477. 2006.PubMed/NCBI
|
|
12
|
Smith DE: The biological paths of IL-1
family members IL-18 and IL-33. J Leukoc Biol. 89:383–392. 2011.
View Article : Google Scholar
|
|
13
|
Moussion C, Ortega N and Girard JP: The
IL-1-like cytokine IL-33 is constitutively expressed in the nucleus
of endothelial cells and epithelial cells in vivo: a novel
‘alarmin’? PLoS One. 3:e33312008. View Article : Google Scholar
|
|
14
|
Sun P, Ben Q, Tu S, Dong W, Qi X and Wu Y:
Serum interleukin-33 levels in patients with gastric cancer. Dig
Dis Sci. 56:3596–3601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Van Cutsem E, Moiseyenko VM, Tjulandin S,
Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi
E, et al: Phase III study of docetaxel and cisplatin plus
fluorouracil compared with cisplatin and fluorouracil as first-line
therapy for advanced gastric cancer: a report of the V325 Study
Group. J Clin Oncol. 24:4991–4997. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzukawa M, Koketsu R, Iikura M, Nakae S,
Matsumoto K, Nagase H, Saito H, Matsushima K, Ohta K, Yamamoto K
and Yamaguchi M: Interleukin-33 enhances adhesion, CD11b expression
and survival in human eosinophils. Lab Invest. 88:1245–1253. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bianchetti L, Marini MA, Isgrò M, Bellini
A, Schmidt M and Mattoli S: IL-33 promotes the migration and
proliferation of circulating fibrocytes from patients with
allergen-exacerbated asthma. Biochem Biophys Res Commun.
426:116–121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
De Vita F, Giuliani F, Silvestris N,
Catalano G, Ciardiello F and Orditura M: Human epidermal growth
factor receptor 2 (HER2) in gastric cancer: a new therapeutic
target. Cancer Treat Rev. 36(Suppl 3): S11–S15. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu Y, Huang S, Liu ZG and Han J:
Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic
cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol
Chem. 281:8788–8795. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu T, Wang Z, Liu Y, Mei Z, Wang G, Liang
Z, Cui A, Hu X, Cui L, Yang Y and Liu CY: Interleukin 22 protects
colorectal cancer cells from chemotherapy by activating the STAT3
pathway and inducing autocrine expression of interleukin 8. Clin
Immunol. 154:116–126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bergis D, Kassis V, Ranglack A, Koeberle
V, Piiper A, Kronenberger B, Zeuzem S, Waidmann O and Radeke HH:
High serum levels of the interleukin-33 receptor soluble ST2 as a
negative prognostic factor in hepatocellular carcinoma. Transl
Oncol. 6:311–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chackerian AA, Oldham ER, Murphy EE,
Schmitz J, Pflanz S and Kastelein RA: IL-1 receptor accessory
protein and ST2 comprise the IL-33 receptor complex. J Immunol.
179:2551–2555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sui X, Kong N, Ye L, Han W, Zhou J, Zhang
Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of
apoptosis and autophagy in response to chemotherapeutic agents.
Cancer Lett. 344:174–179. 2014. View Article : Google Scholar
|
|
24
|
Yuan L, Wang J, Xiao H, Wu W, Wang Y and
Liu X: MAPK signaling pathways regulate mitochondrial-mediated
apoptosis induced by isoorientin in human hepatoblastoma cancer
cells. Food Chem Toxicol. 53:62–68. 2013. View Article : Google Scholar
|
|
25
|
Fan M and Chambers TC: Role of
mitogen-activated protein kinases in the response of tumor cells to
chemotherapy. Drug Resist Updat. 4:253–267. 2001. View Article : Google Scholar
|
|
26
|
Mansouri A, Ridgway LD, Korapati AL, Zhang
Q, Tian L, Wang Y, Siddik ZH, Mills GB and Claret FX: Sustained
activation of JNK/p38 MAPK pathways in response to cisplatin leads
to Fas ligand induction and cell death in ovarian carcinoma cells.
J Biol Chem. 278:19245–19256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davis RJ: Signal transduction by the JNK
group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee ER, Kim JY, Kang YJ, Ahn JY, Kim JH,
Kim BW, Choi HY, Jeong MY and Cho SG: Interplay between PI3K/Akt
and MAPK signaling pathways in DNA-damaging drug-induced apoptosis.
Biochim Biophys Acta. 1763:958–968. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim J, Kim C, Kim TS, Bang SI, Yang Y,
Park H and Cho D: IL-18 enhances thrombospondin-1 production in
human gastric cancer via JNK pathway. Biochem Biophys Res Commun.
344:1284–1289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luan L, Zhao Y, Xu Z, Jiang G, Zhang X,
Fan C, Liu D, Zhao H, Xu K, Wang M, et al: Diversin increases the
proliferation and invasion ability of non-small-cell lung cancer
cells via JNK pathway. Cancer Lett. 344:232–238. 2014. View Article : Google Scholar
|
|
31
|
Fontana VA, Sanchez M, Cebral E and Calvo
JC: Interleukin-1 beta regulates metalloproteinase activity and
leptin secretion in a cytotrophoblast model. Biocell. 34:37–43.
2010.PubMed/NCBI
|
|
32
|
Chen SF, Nieh S, Jao SW, Wu MZ, Liu CL,
Chang YC and Lin YS: The paracrine effect of cancer-associated
fibroblast-induced interleukin-33 regulates the invasiveness of
head and neck squamous cell carcinoma. J Pathol. 231:180–189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jovanovic IP, Pejnovic NN, Radosavljevic
GD, Pantic JM, Milovanovic MZ, Arsenijevic NN and Lukic ML:
Interleukin-33/ST2 axis promotes breast cancer growth and
metastases by facilitating intratumoral accumulation of
immunosuppressive and innate lymphoid cells. Int J Cancer.
134:1669–1682. 2014. View Article : Google Scholar
|
